Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Sandhya Sapra
ResearcherPublications, citations & collaboration network
Sandhya Sapra is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 87 works, 2,072 citations, an h-index of 16 and an i10-index of 22.
87
Works
2,072
Citations
16
h-index
22
i10-index
IDs:OpenAlex
How has Sandhya Sapra's publication output changed over time?
ScholarIQpublication output · 2016–2021
Output grew0% over the shown period — from 1 works in 2016 to 1 in 2021.
1
4
4
1
1
20162017201820192021
What are the most-cited papers on Sandhya Sapra?
ScholarIQmost cited works
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo Bonner, Feng Zhang, Sandhya Sapra, Hernàn Picard, Daniel D. Mikol, Robert Lenz
New England Journal of Medicine. 2017960 CitationsOPEN ACCESS
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
Machaon Bonafede, Sandhya Sapra, Neel Shah, Stewart J. Tepper, Katherine Cappell, Pooja Desai
Headache The Journal of Head and Face Pain. 2018254 Citations
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Sally Mannix, Anne Skalicky, Dawn C. Buse, Pooja Desai, Sandhya Sapra, Brian G. Ortmeier, Katherine L. Widnell, Asha Hareendran
Health and Quality of Life Outcomes. 201694 CitationsOPEN ACCESS
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Dawn C. Buse, Richard B. Lipton, Yngve Hallström, Uwe Reuter, Stewart J. Tepper, Feng Zhang, Sandhya Sapra, Hernàn Picard, Daniel D. Mikol, Robert Lenz
Cephalalgia. 201892 Citations
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective
Richard B. Lipton, Alan Brennan, Stephen Palmer, Anthony J. Hatswell, J. Porter, Sandhya Sapra, Guillermo Villa, Neel Shah, Stewart J. Tepper, David W. Dodick
Journal of Medical Economics. 201864 CitationsOPEN ACCESS
Related on ScholarIQ
Providence College
Institution
A Controlled Trial of Erenumab for Episodic Migraine
Paper
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
Paper
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
Paper
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Paper
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective
Paper